Skip to main content

Advertisement

Attention-Deficit/Hyperactivity Disorder (ADHD) Learning Library

Featured

An illustration of a pencil marking answers on a quiz sheet.
Quiz
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
Julie Carbray
Rapid Refresh
07/26/2024
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute

Rapid Refresh

Julie Carbray
Rapid Refresh
07/26/2024
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute
Julie Carbray
Rapid Refresh
07/26/2024
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute
andrew and julie
Rapid Refresh
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
amber and brooke
Rapid Refresh
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke...
04/10/2024
Psych Congress NP Institute

Expert Insights Quizzes

An illustration of a pencil marking answers on a quiz sheet.
Quiz
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
An illustration of a pencil marking answers on a quiz sheet.
Quiz
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
quiz
Quiz
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there...
07/19/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
07/15/2024
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not...
07/15/2024
Psych Congress NP Institute
Why are clinicians wary of antipsychotic use in MDD treatment?
Expert Insights Quiz
07/27/2023

With Craig Chepke, MD, DFAPA

With Craig Chepke, MD, DFAPA
Time for a pop quiz!
Time for a pop quiz!
Time for a pop quiz!
07/27/2023
Psych Congress Network